IRIDEX Free Cash Flow 2010-2024 | IRIX
IRIDEX free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| IRIDEX Annual Free Cash Flow |
| 2023 |
-6.85 |
| 2022 |
-9.81 |
| 2021 |
8.00 |
| 2020 |
-3.33 |
| 2019 |
-8.04 |
| 2018 |
-10.47 |
| 2017 |
-4.14 |
| 2016 |
-1.21 |
| 2015 |
-1.47 |
| 2014 |
3.45 |
| 2013 |
0.39 |
| 2012 |
-1.53 |
| 2011 |
2.05 |
| 2010 |
0.94 |
| 2009 |
2.82 |
| IRIDEX Quarterly Free Cash Flow |
| 2024-03-31 |
-1.65 |
| 2023-12-31 |
-6.85 |
| 2023-09-30 |
-5.91 |
| 2023-06-30 |
-4.04 |
| 2023-03-31 |
-2.89 |
| 2022-12-31 |
-9.81 |
| 2022-09-30 |
-8.13 |
| 2022-06-30 |
-5.97 |
| 2022-03-31 |
-3.28 |
| 2021-12-31 |
8.00 |
| 2021-09-30 |
9.78 |
| 2021-06-30 |
10.47 |
| 2021-03-31 |
11.76 |
| 2020-12-31 |
-3.33 |
| 2020-09-30 |
-3.11 |
| 2020-06-30 |
-3.52 |
| 2020-03-31 |
-1.52 |
| 2019-12-31 |
-8.04 |
| 2019-09-30 |
-7.85 |
| 2019-06-30 |
-5.27 |
| 2019-03-31 |
-3.86 |
| 2018-12-31 |
-10.47 |
| 2018-09-30 |
-8.37 |
| 2018-06-30 |
-5.43 |
| 2018-03-31 |
-3.00 |
| 2017-12-31 |
-4.14 |
| 2017-09-30 |
-3.18 |
| 2017-06-30 |
-1.19 |
| 2017-03-31 |
-1.96 |
| 2016-12-31 |
-1.21 |
| 2016-09-30 |
-0.60 |
| 2016-06-30 |
1.46 |
| 2016-03-31 |
0.44 |
| 2015-12-31 |
-1.47 |
| 2015-09-30 |
-1.09 |
| 2015-06-30 |
-0.20 |
| 2015-03-31 |
0.22 |
| 2014-12-31 |
3.45 |
| 2014-09-30 |
2.19 |
| 2014-06-30 |
1.08 |
| 2014-03-31 |
0.54 |
| 2013-12-31 |
0.39 |
| 2013-09-30 |
1.12 |
| 2013-06-30 |
0.59 |
| 2013-03-31 |
-0.42 |
| 2012-12-31 |
-1.53 |
| 2012-09-30 |
-1.86 |
| 2012-06-30 |
-1.98 |
| 2012-03-31 |
-1.36 |
| 2011-12-31 |
2.05 |
| 2011-09-30 |
0.59 |
| 2011-06-30 |
-0.54 |
| 2011-03-31 |
-0.76 |
| 2010-12-31 |
0.94 |
| 2010-09-30 |
1.40 |
| 2010-06-30 |
1.30 |
| 2010-03-31 |
0.51 |
| 2009-12-31 |
2.82 |
| 2009-09-30 |
5.12 |
| 2009-06-30 |
2.84 |
| 2009-03-31 |
0.85 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.043B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
